首頁 > 市場調查報告書 > 製藥

孤兒藥

市場調查報告書

商品編碼

1636336

2025-2033 年法布瑞氏症市場報告（按類型（1 型、2 型等）、診斷和治療（診斷、治療）、最終用戶（醫院、家庭護理、專科診所等）和地區）

Fabry Disease Market Report by Type (Type 1, Type 2, and Others), Diagnosis and Treatment (Diagnosis, Treatment), End User (Hospitals, Homecare, Specialty Clinics, and Others), and Region 2025-2033

出版日期: 2025年01月10日 | 出版商:

IMARC | 英文 130 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

2024年，全球法布瑞氏症市場IMARC Group達21億美元。患有法布瑞氏症的患者數量不斷增加，以及對遺傳和酵素替代療法等有效新療法的需求不斷增加，是推動市場發展的一些關鍵因素。

法布瑞氏症或α 半乳糖苷酶A 缺乏症是一種嚴重的X 連鎖溶小體遺傳性疾病，由缺乏代謝各種脂質儲存和脂肪樣成分（包括油、脂肪酸和蠟）所需的酶引起。如果不及時診斷或治療，可能會導致血管和組織阻塞、進行性腎衰竭、神經損傷，甚至中風。目前，法布瑞氏症可以在酵素替代療法（ERT）和輔助療法的支持下進行治療。除此之外，還可以透過基因、血液、腸外檢查進一步確診，抑制腎臟、心臟問題的發生。這些方法可防止發生一級和二級併發症的風險，並糾正潛在的酵素缺乏症。因此，醫院和專科診所廣泛採用各種程序來及時診斷和有效治療法布瑞氏症。

法布瑞氏症市場趨勢：

患有法布瑞氏症的患者數量不斷增加，以及對精確有效療法的需求不斷增加，例如遺傳、酵素替代底物減少和穩定個體免受疾病影響的伴侶治療，是推動市場成長的主要動力。與此一致的是，對用於疾病治療的口服藥物和膠囊的需求不斷成長是另一個成長誘導因素。此外，監管機構為投資醫療保健產業以設計突破性疾病治療方案所採取的有利措施正在支持市場成長。此外，重大技術進步，例如用於診斷和治療法布瑞氏症的遠距醫療解決方案和家庭護理設置的引入，有利於市場成長。人們對該疾病的認知不斷提高，也大大推動了市場的發展。醫生和個人對早期診斷和多種預防措施的可用性的認知不斷增強，這有助於市場的成長。老年人口不斷增加，容易患任何慢性疾病，這是推動市場成長的另一個因素。其他因素，例如醫療保健基礎設施的顯著改善、對遺傳疾病療法進步的更加關注以及擴大治療和藥物組合的持續研發（R＆D）活動，正在為市場創造積極的前景。

本報告回答的關鍵問題：

迄今為止，全球法布瑞氏症市場表現如何，未來幾年將如何表現？
全球法布瑞氏症市場的促進因素、限制因素和機會是什麼？
主要區域市場有哪些？
哪些國家代表了最具吸引力的法布瑞氏症市場？
依類型分類市場是怎麼樣的？
基於診斷和治療的市場區隔是什麼？
基於最終用戶的市場區隔是什麼？
全球法布瑞氏症市場的競爭結構如何？
誰是全球法布瑞氏症市場的主要參與者/公司？

The global fabry disease market size reached USD 2.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 3.7 Billion by 2033, exhibiting a growth rate (CAGR) of 6.02% during 2025-2033. The increasing number of patients suffering from fabry disease and the escalating need for effective novel therapies, such as genetic and enzyme replacement therapy, represent some of the key factors driving the market.

Fabry disease, or alpha galactosidase-A deficiency, represents a severe x-linked lysosomal inherited disorder that is caused by the lack of enzymes that are required to metabolize various lipid storage and fat-like components, including oils, fatty acids, and waxes. If left undiagnosed or untreated, it might result in clogging of blood vessels and tissue, progressive kidney failures, nerve damage, and even strokes. Currently, fabry disease can be treated with the support of enzyme replacement therapies (ERT) and adjunct therapy. Apart from this, it can be further diagnosed through genetic, blood, and parenteral examinations to inhibit the occurrence of kidney and heart problems. These approaches prevent the risk of developing first and second-level complications and correct underlying enzyme deficiency. Consequently, hospitals and specialty clinics widely utilize various procedures for the timely diagnosis and effective treatment of the Fabry disease.

Fabry Disease Market Trends:

The increasing number of patients suffering from fabry disease and the escalating need for precise and effective therapies, such as genetic, enzyme replacement substrate reduction, and chaperone treatments to stabilize individuals from suffering disease, are primarily driving the market growth. In line with this, the rising demand for orally administered medications and capsule for disease treatment is acting as another growth-inducing factor. Additionally, the favorable initiatives being undertaken by regulatory bodies to invest in the healthcare sector for the designing of breakthrough disease treatment options are supporting the market growth. Moreover, significant technological advancements, such as the introduction of telemedicine solutions and home care settings for the diagnosis and treatment of Fabry disease, are favoring the market growth. The market is also significantly driven by the rising awareness regarding the disease. There is an increasing consciousness regarding the availability of early-stage diagnosis and multiple preventive measures amongst physicians and individuals, which is contributing to the market growth. The steadily increasing geriatric population, which is susceptible to any kind of chronic ailments, is another factor contributing to the market growth. Other factors, such as significant improvements in the healthcare infrastructure, an enhanced focus on the advancement of the genetic disease therapies, and continuous research and development (R&D) activities to expand treatment and medication portfolios, are creating a positive outlook for the market.

Key Market Segmentation:

Type Insights:

Type 1
Type 2
Others
The report has also provided a detailed breakup and analysis of the fabry disease market based on the type. This includes Type 1, Type 2 and others.

Diagnosis and Treatment Insights:

Diagnosis
Blood Test
Genetic Test
Parenteral Test
Others
Treatment
Enzyme Replacement Therapy
Oral Therapy
Adjunct Therapy
Others

End User Insights:

Hospitals
Homecare
Specialty Clinics
Others

Regional Insights:

North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and Middle East and Africa. According to the report, North America was the largest market for Fabry disease. Some of the factors driving the North America fabry disease market included the increasing prevalence of fabry disease and the ongoing approvals of advanced therapeutics by regional governments for the disorder treatment.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global fabry disease market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Amicus Therapeutics, Freeline, Idorsia Pharmaceuticals Ltd, JCR Pharmaceuticals Co. Ltd, Protalix BioTherapeutics, Sangamo Therapeutics Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

How has the global fabry disease market performed so far and how will it perform in the coming years?
What are the drivers, restraints, and opportunities in the global fabry disease market?
What are the key regional markets?
Which countries represent the most attractive fabry disease markets?
What is the breakup of the market based on the type?
What is the breakup of the market based on the diagnosis and treatment?
What is the breakup of the market based on the end user?
What is the competitive structure of the global fabry disease market?
Who are the key players/companies in the global fabry disease market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Fabry Disease Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Type

6.1 Type 1
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Type 2
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
6.3 Others
- 6.3.1 Market Trends
- 6.3.2 Market Forecast

7 Market Breakup by Diagnosis & Treatment

7.1 Diagnosis
- 7.1.1 Market Trends
- 7.1.2 Key Segments
  - 7.1.2.1 Blood Test
  - 7.1.2.2 Genetic Test
  - 7.1.2.3 Parenteral Test
  - 7.1.2.4 Others
- 7.1.3 Market Forecast
7.2 Treatment
- 7.2.1 Market Trends
- 7.2.2 Key Segments
  - 7.2.2.1 Enzyme Replacement Therapy
  - 7.2.2.2 Oral Therapy
  - 7.2.2.3 Adjunct Therapy
  - 7.2.2.4 Others
- 7.2.3 Market Forecast

8 Market Breakup by End User

8.1 Hospitals
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Homecare
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Specialty Clinics
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
8.4 Others
- 8.4.1 Market Trends
- 8.4.2 Market Forecast

9 Market Breakup by Region

9.1 North America
- 9.1.1 United States
  - 9.1.1.1 Market Trends
  - 9.1.1.2 Market Forecast
- 9.1.2 Canada
  - 9.1.2.1 Market Trends
  - 9.1.2.2 Market Forecast
9.2 Asia-Pacific
- 9.2.1 China
  - 9.2.1.1 Market Trends
  - 9.2.1.2 Market Forecast
- 9.2.2 Japan
  - 9.2.2.1 Market Trends
  - 9.2.2.2 Market Forecast
- 9.2.3 India
  - 9.2.3.1 Market Trends
  - 9.2.3.2 Market Forecast
- 9.2.4 South Korea
  - 9.2.4.1 Market Trends
  - 9.2.4.2 Market Forecast
- 9.2.5 Australia
  - 9.2.5.1 Market Trends
  - 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
  - 9.2.6.1 Market Trends
  - 9.2.6.2 Market Forecast
- 9.2.7 Others
  - 9.2.7.1 Market Trends
  - 9.2.7.2 Market Forecast
9.3 Europe
- 9.3.1 Germany
  - 9.3.1.1 Market Trends
  - 9.3.1.2 Market Forecast
- 9.3.2 France
  - 9.3.2.1 Market Trends
  - 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
  - 9.3.3.1 Market Trends
  - 9.3.3.2 Market Forecast
- 9.3.4 Italy
  - 9.3.4.1 Market Trends
  - 9.3.4.2 Market Forecast
- 9.3.5 Spain
  - 9.3.5.1 Market Trends
  - 9.3.5.2 Market Forecast
- 9.3.6 Russia
  - 9.3.6.1 Market Trends
  - 9.3.6.2 Market Forecast
- 9.3.7 Others
  - 9.3.7.1 Market Trends
  - 9.3.7.2 Market Forecast
9.4 Latin America
- 9.4.1 Brazil
  - 9.4.1.1 Market Trends
  - 9.4.1.2 Market Forecast
- 9.4.2 Mexico
  - 9.4.2.1 Market Trends
  - 9.4.2.2 Market Forecast
- 9.4.3 Others
  - 9.4.3.1 Market Trends
  - 9.4.3.2 Market Forecast
9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast

10 Drivers, Restraints, and Opportunities

10.1 Overview
10.2 Drivers
10.3 Restraints
10.4 Opportunities

11 Value Chain Analysis

12 Porters Five Forces Analysis

12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
- 14.3.1 Amicus Therapeutics
  - 14.3.1.1 Company Overview
  - 14.3.1.2 Product Portfolio
  - 14.3.1.3 Financials
  - 14.3.1.4 SWOT Analysis
- 14.3.2 Freeline
  - 14.3.2.1 Company Overview
  - 14.3.2.2 Product Portfolio
- 14.3.3 Idorsia Pharmaceuticals Ltd
  - 14.3.3.1 Company Overview
  - 14.3.3.2 Product Portfolio
  - 14.3.3.3 Financials
- 14.3.4 JCR Pharmaceuticals Co. Ltd
  - 14.3.4.1 Company Overview
  - 14.3.4.2 Product Portfolio
  - 14.3.4.3 Financials
  - 14.3.4.4 SWOT Analysis
- 14.3.5 Protalix BioTherapeutics
  - 14.3.5.1 Company Overview
  - 14.3.5.2 Product Portfolio
- 14.3.6 Sangamo Therapeutics Inc.
  - 14.3.6.1 Company Overview
  - 14.3.6.2 Product Portfolio
  - 14.3.6.3 Financials
  - 14.3.6.4 SWOT Analysis

Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.

簡介目錄圖表

List of Figures

Figure 1: Global: Fabry Disease Market: Major Drivers and Challenges
Figure 2: Global: Fabry Disease Market: Sales Value (in Billion USD), 2019-2024
Figure 3: Global: Fabry Disease Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 4: Global: Fabry Disease Market: Breakup by Type (in %), 2024
Figure 5: Global: Fabry Disease Market: Breakup by Diagnosis & Treatment (in %), 2024
Figure 6: Global: Fabry Disease Market: Breakup by End User (in %), 2024
Figure 7: Global: Fabry Disease Market: Breakup by Region (in %), 2024
Figure 8: Global: Fabry Disease (Type 1) Market: Sales Value (in Million USD), 2019 & 2024
Figure 9: Global: Fabry Disease (Type 1) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 10: Global: Fabry Disease (Type 2) Market: Sales Value (in Million USD), 2019 & 2024
Figure 11: Global: Fabry Disease (Type 2) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 12: Global: Fabry Disease (Other Types) Market: Sales Value (in Million USD), 2019 & 2024
Figure 13: Global: Fabry Disease (Other Types) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 14: Global: Fabry Disease (Diagnosis) Market: Sales Value (in Million USD), 2019 & 2024
Figure 15: Global: Fabry Disease (Diagnosis) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 16: Global: Fabry Disease (Treatment) Market: Sales Value (in Million USD), 2019 & 2024
Figure 17: Global: Fabry Disease (Treatment) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 18: Global: Fabry Disease (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
Figure 19: Global: Fabry Disease (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 20: Global: Fabry Disease (Homecare) Market: Sales Value (in Million USD), 2019 & 2024
Figure 21: Global: Fabry Disease (Homecare) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 22: Global: Fabry Disease (Specialty Clinics) Market: Sales Value (in Million USD), 2019 & 2024
Figure 23: Global: Fabry Disease (Specialty Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 24: Global: Fabry Disease (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
Figure 25: Global: Fabry Disease (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 26: North America: Fabry Disease Market: Sales Value (in Million USD), 2019 & 2024
Figure 27: North America: Fabry Disease Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 28: United States: Fabry Disease Market: Sales Value (in Million USD), 2019 & 2024
Figure 29: United States: Fabry Disease Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 30: Canada: Fabry Disease Market: Sales Value (in Million USD), 2019 & 2024
Figure 31: Canada: Fabry Disease Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 32: Asia-Pacific: Fabry Disease Market: Sales Value (in Million USD), 2019 & 2024
Figure 33: Asia-Pacific: Fabry Disease Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 34: China: Fabry Disease Market: Sales Value (in Million USD), 2019 & 2024
Figure 35: China: Fabry Disease Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 36: Japan: Fabry Disease Market: Sales Value (in Million USD), 2019 & 2024
Figure 37: Japan: Fabry Disease Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 38: India: Fabry Disease Market: Sales Value (in Million USD), 2019 & 2024
Figure 39: India: Fabry Disease Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 40: South Korea: Fabry Disease Market: Sales Value (in Million USD), 2019 & 2024
Figure 41: South Korea: Fabry Disease Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 42: Australia: Fabry Disease Market: Sales Value (in Million USD), 2019 & 2024
Figure 43: Australia: Fabry Disease Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 44: Indonesia: Fabry Disease Market: Sales Value (in Million USD), 2019 & 2024
Figure 45: Indonesia: Fabry Disease Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 46: Others: Fabry Disease Market: Sales Value (in Million USD), 2019 & 2024
Figure 47: Others: Fabry Disease Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 48: Europe: Fabry Disease Market: Sales Value (in Million USD), 2019 & 2024
Figure 49: Europe: Fabry Disease Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 50: Germany: Fabry Disease Market: Sales Value (in Million USD), 2019 & 2024
Figure 51: Germany: Fabry Disease Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 52: France: Fabry Disease Market: Sales Value (in Million USD), 2019 & 2024
Figure 53: France: Fabry Disease Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 54: United Kingdom: Fabry Disease Market: Sales Value (in Million USD), 2019 & 2024
Figure 55: United Kingdom: Fabry Disease Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 56: Italy: Fabry Disease Market: Sales Value (in Million USD), 2019 & 2024
Figure 57: Italy: Fabry Disease Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 58: Spain: Fabry Disease Market: Sales Value (in Million USD), 2019 & 2024
Figure 59: Spain: Fabry Disease Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 60: Russia: Fabry Disease Market: Sales Value (in Million USD), 2019 & 2024
Figure 61: Russia: Fabry Disease Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 62: Others: Fabry Disease Market: Sales Value (in Million USD), 2019 & 2024
Figure 63: Others: Fabry Disease Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 64: Latin America: Fabry Disease Market: Sales Value (in Million USD), 2019 & 2024
Figure 65: Latin America: Fabry Disease Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 66: Brazil: Fabry Disease Market: Sales Value (in Million USD), 2019 & 2024
Figure 67: Brazil: Fabry Disease Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 68: Mexico: Fabry Disease Market: Sales Value (in Million USD), 2019 & 2024
Figure 69: Mexico: Fabry Disease Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 70: Others: Fabry Disease Market: Sales Value (in Million USD), 2019 & 2024
Figure 71: Others: Fabry Disease Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 72: Middle East and Africa: Fabry Disease Market: Sales Value (in Million USD), 2019 & 2024
Figure 73: Middle East and Africa: Fabry Disease Market: Breakup by Country (in %), 2024
Figure 74: Middle East and Africa: Fabry Disease Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 75: Global: Fabry Disease Industry: Drivers, Restraints, and Opportunities
Figure 76: Global: Fabry Disease Industry: Value Chain Analysis
Figure 77: Global: Fabry Disease Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Fabry Disease Market: Key Industry Highlights, 2024 and 2033
Table 2: Global: Fabry Disease Market Forecast: Breakup by Type (in Million USD), 2025-2033
Table 3: Global: Fabry Disease Market Forecast: Breakup by Diagnosis & Treatment (in Million USD), 2025-2033
Table 4: Global: Fabry Disease Market Forecast: Breakup by End User (in Million USD), 2025-2033
Table 5: Global: Fabry Disease Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 6: Global: Fabry Disease Market: Competitive Structure
Table 7: Global: Fabry Disease Market: Key Players

02-2729-4219

+886-2-2729-4219